drugset / Trial / NCT02082912

NMDA Receptors in Motor Learning in Humans

NCT02082912

Phase 2 Completed 14 enrolled Emory University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to focus on enhancing upper limb recovery in patients post-stroke by using robotic-assisted therapy in combination with a drug to improve learning new motor skills.

Timeline

Start
2010-06
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Cycloserine Small molecule 100 mg Oral

Indications